ARTICLE IExecutive Change in Control Severance Benefits Agreement • April 23rd, 1999 • Continuus Software Corp /Ca • California
EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • August 12th, 2002 • Intersil Corp/De • Semiconductors & related devices • California
THIS EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT (the “AGREEMENT” ) is entered into on May 14, 2002, between Mohan Maheswaran (“Executive”) and INTERSIL CORPORATION , a Delaware corporation (the “COMPANY” ).
AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • May 18th, 2011 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
This Amended and Restated Executive Change in Control Severance Benefits Agreement (the “Agreement”) is entered into as of May 18, 2011 (the “Effective Date”), between Kaye Foster-Cheek (“Executive”) and Onyx Pharmaceuticals, Inc. (the “Company”) and amends and restates the prior Executive Change in Control Severance Benefits Agreement between the Company and Executive dated September 30, 2010 (the “Original Date”). This Agreement is intended to provide Executive with certain compensation and benefits in the event that Executive is subject to a qualifying termination of employment in connection with a Change in Control. Certain capitalized terms used in this Agreement are defined in Article 5.
SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • April 12th, 2013 • Portola Pharmaceuticals Inc • Pharmaceutical preparations • California
This EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is amended and restated as of [date] (the “Effective Date”), between [EXECUTIVE] (“Executive”) and PORTOLA PHARMACEUTICALS, INC. (the “Company”). This Agreement is intended to provide Executive with certain compensation and benefits in the event that Executive is subject to certain qualifying terminations of employment in connection with a Change in Control. Certain capitalized terms used in this Agreement are defined in Article 5.
ContractExecutive Change in Control Severance Benefits Agreement • May 16th, 2001 • Elantec Semiconductor Inc • Semiconductors & related devices • California
EXHIBIT 10.19 EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT THIS EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT (the “AGREEMENT”) is entered into on between (“Executive”) and ELANTEC SEMICONDUCTOR, INC., a Delaware corporation (the “COMPANY”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article VI. The Company and Executive hereby agree as follows: ARTICLE 1 EMPLOYMENT BY THE COMPANY 1.1 Executive is currently employed as an executive of the Company. 1.2 This Agreement shall remain in full force and effect so long as Executive is employed by Company; provided, however, that the rights and obligations of the parties hereto contained in Articles II through VII shall survive Two and One Half (2-1/2) years following a Covered Termination (as hereinafter defined). 1.3 The Company and Executive wish to set forth t
EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • October 16th, 2013 • Intersil Corp/De • Semiconductors & related devices • California
THIS EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT (the “AGREEMENT”) is entered into on October 14, 2013, between Roger Wendelken (“Executive”) and INTERSIL CORPORATION, a Delaware corporation (the “COMPANY”).
EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • May 15th, 2001 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
This EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT (the "Agreement") is entered into as of the day of , 2001 (the "Effective Date"), between ("Executive") and ONYX PHARMACEUTICALS, INC. (the "Company"). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 5.
AMENDMENT NO. 1 TO AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • August 6th, 2012 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
This AMENDMENT NO. 1 TO AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT (the “Amendment”) is made and entered into, as of July 26, 2012 (the “Effective Date”), between ONYX PHARMACEUTICALS, INC., a Delaware corporation (“Company”), and KAYE FOSTER-CHEEK (“Executive”). As of the Effective Date, the Company and Executive hereby amend that certain AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT between the Company and Executive dated May 18, 2011 (the “Agreement”), a copy of which is attached hereto as Exhibit A, as follows:
EX-10.6 9 dex106.htm FORM OF SEVERANCE BENEFITS AGMT - CERTAIN EXECUTIVES EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • May 5th, 2020 • California
THIS EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT (the “AGREEMENT” ) is entered into on ____________2002, between ______________ (“Executive”) and INTERSIL CORPORATION , a Delaware corporation (the “COMPANY” ).
AMENDED and RESTATED EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • February 12th, 2016 • Intersil Corp/De • Semiconductors & related devices • California
THIS AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into on _____________________, between ________________ (“Executive”) and INTERSIL CORPORATION, a Delaware corporation (the “Company”).
EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • June 25th, 2004 • Intersil Corp/De • Semiconductors & related devices • California
THIS EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT (the “AGREEMENT”) is entered into on March 15, 2004, between Louis DiNardo (“Executive”) and INTERSIL CORPORATION, a Delaware corporation (the “COMPANY”).
EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • May 2nd, 2008 • Intersil Corp/De • Semiconductors & related devices • California
THIS EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT (the “AGREEMENT”) is entered into on April 4, 2008, between David B. Bell (“Executive”) and INTERSIL CORPORATION, a Delaware corporation (the “COMPANY”).
ONYX PHARMACEUTICALS, INC. FORM OF EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • November 9th, 2005 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
This form of Executive Change in Control Severance Benefits Agreement may be entered into between Onyx Pharmaceuticals, Inc. and each of its Chief Executive officer (“CEO”), Executive Vice Presidents (“EVP”), Senior Vice Presidents (“SVP”) and Vice Presidents (“VP”). This agreement provides for different levels of benefits for the CEO, for EVP and SVP, and for VP. Where the benefit levels differ among executive classifications, the benefit levels for each executive classification are indicated in this form of agreement in bracketed and italicized text.
BROADSOFT, INC. EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • March 15th, 2010 • Broadsoft Inc • Maryland
This Executive Change in Control Severance Benefits Agreement (the “Agreement”) is entered into as of , 20 (the “Effective Date”), by and between Name of Executive (the “Executive”) and BroadSoft, Inc., a Delaware corporation (the “Company”).
AMENDMENT TO EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • March 6th, 2006 • Intersil Corp/De • Semiconductors & related devices
WHEREAS, on May 10, 2002, Richard M. Beyer (“Executive”) and Intersil Corporation, a Delaware corporation (the “Company” ) entered into an Executive Change In Control Severance Benefits Agreement (the “Agreement”);
AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • May 27th, 2010 • Intersil Corp/De • Semiconductors & related devices • California
THIS AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT (the “AGREEMENT”) is entered into on May 4, 2010, between David B. Bell (“EXECUTIVE”) and INTERSIL CORPORATION, a Delaware corporation (the “COMPANY”).
EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • March 12th, 2013 • Intersil Corp/De • Semiconductors & related devices • California
THIS EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT (the “AGREEMENT”) is entered into on March 14, 2013, between Necip Sayiner (“Executive”) and INTERSIL CORPORATION, a Delaware corporation (the “COMPANY”).
ContractExecutive Change in Control Severance Benefits Agreement • December 26th, 2001 • Elantec Semiconductor Inc • Semiconductors & related devices • California
Exhibit 10.09 EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT THIS EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT (the “AGREEMENT”) was entered into on February 13, 2001, between Richard M. Beyer (“Executive”) and ELANTEC SEMICONDUCTOR, INC., a Delaware corporation (the “COMPANY”). It is hereby amended and clarified November 12, 2001 effective as of February 13, 2001. This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article VI. The Company and Executive hereby agree as follows: ARTICLE 1 EMPLOYMENT BY THE COMPANY 1.1 Executive is currently employed as an executive of the Company. 1.2 This Agreement shall remain in full force and effect so long as Executive is employed by Company; provided, however, that the rights and obligations of the parties hereto contained in Articles II through VII shall survive Two and One
AMENDMENT TO EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENTExecutive Change in Control Severance Benefits Agreement • March 6th, 2006 • Intersil Corp/De • Semiconductors & related devices
WHEREAS, on March 15, 2004, Louis DiNardo (“Executive”) and Intersil Corporation, a Delaware corporation (the “Company” ) entered into an Executive Change In Control Severance Benefits Agreement (the “Agreement”);
